Postdoctoral Fellow in Airway-Targeted Tuberculosis Vaccine Development, Structural Serology and Antigen Design

The TB Vaccine Research Group at Statens Serum Institut (SSI) and the Structural Biology and Protein Design Group within Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) at the University of Copenhagen (NIVI) are seeking a highly motivated postdoctoral fellow for a joint position spanning vaccine development, immunology, structural biology, and vaccine design strategies optimized for pulmonary immunity.

The successful candidate will divide their time between both research environments, contributing to the development and evaluation of next-generation tuberculosis vaccine strategies through preclinical immunology, structural characterization of immune responses, antigen and epitope discovery, and structure-guided protein engineering.

The position is offered for three years, with a preferred starting date as sson as possible. Some flexibility in start date may be possible. The department and research group The Department of Infectious Disease Immunology focuses on research and development of next-generation vaccines and diagnostic tools, primarily within tuberculosis (TB), chlamydia, and vaccine adjuvants.

The Department conducts both basic and translational research and is highly rated internationally. As part of the SSI Center for Vaccine Research, we can efficiently move products from research into clinical trials1 …